Skip to content

Alain Rinaldi

  • MD
  • Founder & CEO
  • MEDExpansion

    About

    Elaboration of phase 1/2 clinical protocols in molecular oncology Development of circulating biomarkers in oncology

    Professional experience

    Founder & CEO

    MEDExpansion

    January 2014 - Present